Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Life Science Strategy Group provides strategic consulting and market research services to the biopharmaceutical industry with deep expertise in supporting Contract Research Organizations (CROs), Contract Development and Manufacturing Organizations (CDMOs), pharmaceutical companies, biotechnology firms, diagnostics companies, medical device manufacturers, and related sectors. The firm specializes in new product planning, commercialization strategy, opportunity assessments, pricing/reimbursement analysis, competitive benchmarking and market analytics. It has served more than half of the global top 10 CROs as clients[1][2][5][6].
The company does not develop its own therapeutic products or maintain an R&D pipeline.
Its leadership team brings decades of experience across business strategy and life sciences[3].
Founded in Menlo Park in 2007 by Ken Smith (MBA) and Jon Meyer (MSc/MBA), LSSG operates as an independent consultancy with approximately ten employees[2][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Life Science Strategy Group.